Diabetes Therapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.2 | Q2 | 67.5% | 1.137 | Q1 | 87.0% |
| 2024 | 2.6 | Q3 | 41.5% | 1.070 | Q2 | 85.9% |
| 2023 | 2.8 | Q3 | 47.7% | 0.938 | Q2 | 83.9% |
| 2022 | 3.8 | Q2 | 58.7% | 1.039 | Q1 | 87.1% |
| 2021 | 3.6 | Q3 | 51.6% | 0.902 | Q2 | 84.3% |
| 2020 | — | — | 0.907 | Q2 | 82.9% | |
| 2019 | — | — | 1.120 | Q1 | 88.0% | |
| 2018 | — | — | 0.953 | Q2 | 83.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1869-6953
ISSN
1869-6961
region
Western Europe
coverage
2010-2026